EHRA Premium Access

Clinical predictors of time-to-first appropriate implantable cardioverter-defibrillator discharge in high-risk patients with Brugada syndrome implanted prophylactically: analysis of 246 patients from

Topic: Primary prevention (Sudden cardiac death and implantable defibrillators)

Congress Presentation

About the speaker

Professor Bernard Belhassen

Hadassah-Hebrew University, Jerusalem (Israel)
1 follower

13 more presentations in this session

Which is the benefit of ICD in patients with ischemic cardiomyopathy compare with those with idiopathic dilated cardiomyopathy, from DANISH trial to real life.

Speaker: Doctor A. Tronconi (Buenos Aires, AR)

Thumbnail

Validation of a madit-ii derived, primary prevention mortality risk score after implantable cardioverter-defibrillator implantation

Speaker: Doctor J. Acosta Martinez (Seville, ES)

Thumbnail

Clinical outcomes after implantable cardioverter-defibrillator implantation: does gender matter? a propensity score analysis

Speaker: Doctor J. Acosta Martinez (Seville, ES)

Thumbnail

Are implantable defibrillators less useful in patients with non-ischemic heart disease?

Speaker: Doctor A. Marinheiro (Setubal, PT)

Thumbnail

Survival analysis in patients with and without implantable cardioverter defibrillator for primary prevention indication: a single-centre multiethnic experience

Speaker: Miss A. Ayemon (Southampton, GB)

Thumbnail

Access the full session

Poster session 1 - Sudden cardiac death and implantable defibrillators

Speakers: Professor B. Belhassen, Doctor A. Tronconi, Doctor J. Acosta Martinez, Doctor J. Acosta Martinez, Doctor A. Marinheiro...
Thumbnail

About the event

Image

EHRA EUROPACE - CARDIOSTIM 2017

18 June - 21 June 2017

Sessions Presentations

ESC 365 is supported by